Revenue Breakdown
Composition ()
No data
Revenue Streams
Biote Corp (BTMD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pellet Procedures, accounting for 72.0% of total sales, equivalent to $35.20M. Other significant revenue streams include Dietary Supplements and Disposable Trocars. Understanding this composition is critical for investors evaluating how BTMD navigates market cycles within the Professional Information Services industry.
Profitability & Margins
Evaluating the bottom line, Biote Corp maintains a gross margin of 71.77%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 19.58%, while the net margin is 19.22%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively BTMD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, BTMD competes directly with industry leaders such as VMD and CYH. With a market capitalization of $95.66M, it holds a significant position in the sector. When comparing efficiency, BTMD's gross margin of 71.77% stands against VMD's 56.94% and CYH's 81.60%. Such benchmarking helps identify whether Biote Corp is trading at a premium or discount relative to its financial performance.
